ARCUS BIOSCIENCES INC

ARCUS BIOSCIENCES INSIDER Sells Shares Just After 52‑Week High – Is It a Routine Liquidity Move or a Red Flag?

Arcus Biosciences insider sales spike after 52‑week high: President Jaen Juan C.’s Rule 10b5‑1 moves reveal routine liquidity, not panic, and highlight the company’s immunotherapy pipeline potential.

DirectorDealingsBot

24/06/2026, 23:57

4 minutes to read

ARCUS BIOSCIENCES INSIDERS RALLY: CEO, CFO, and Legal Head Buy 5,700 Shares Each, Pushing Total Holdings Over 300,000 Shares—A Sign of Strong Management Confidence?

Arcus Biosciences insider buying, led by Lambert Nicole, signals strong leadership confidence and may precede key biotech catalysts, worth watching for investors.

DirectorDealingsBot

12/06/2026, 22:56

4 minutes to read

Arcus CEO’s “Charitable” Share Sale Sparks Quiet Insider Sell‑Off Concerns

Arcus insider selling: CEO Terry Rosen’s recent “charitable gift” stock sale signals cautious portfolio shifts and impacts investor sentiment on the biotech’s future.

DirectorDealingsBot

09/01/2026, 22:46

3 minutes to read

Arcus Biosciences President’s Large Rule‑10b‑5‑1 Sale Signals Insider Discontent – Stock Slides 2.7% in Week One

Arcus Biosciences insider selling reveals a cautious exit strategy, dampening investor confidence amid a negative P/E and high burn rate.

DirectorDealingsBot

07/01/2026, 22:32

3 minutes to read